187 related articles for article (PubMed ID: 14739491)
1. Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma.
Powers JF; Brachold JM; Tischler AS
Endocr Pathol; 2003; 14(4):351-61. PubMed ID: 14739491
[TBL] [Abstract][Full Text] [Related]
2. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
3. Adrenal ganglioneuromas in children with multiple endocrine neoplasia type 2: a report of two cases.
Lora MS; Waguespack SG; Moley JF; Walvoord EC
J Clin Endocrinol Metab; 2005 Jul; 90(7):4383-7. PubMed ID: 15827098
[TBL] [Abstract][Full Text] [Related]
4. The RET proto-oncogene in sporadic pheochromocytomas.
Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
[TBL] [Abstract][Full Text] [Related]
5. Adrenergic differentiation and Ret expression in rat pheochromocytomas.
Powers JF; Picard KL; Nyska A; Tischler AS
Endocr Pathol; 2008; 19(1):9-16. PubMed ID: 18317952
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of ret by reserpine in the adult rat adrenal medulla.
Powers JF; Brachold JM; Ehsani SA; Tischler AS
Neuroscience; 2005; 132(3):605-12. PubMed ID: 15837122
[TBL] [Abstract][Full Text] [Related]
7. Absence of mutations at codon 768 of the RET proto-oncogene in sporadic and hereditary pheochromocytomas.
Yoshimoto K; Kimura T; Tanaka C; Moritani M; Iwahana H; Itakura M
Endocr J; 1996 Feb; 43(1):109-14. PubMed ID: 8732460
[TBL] [Abstract][Full Text] [Related]
8. Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin.
Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
J Mol Med (Berl); 1996 Oct; 74(10):617-21. PubMed ID: 8912182
[TBL] [Abstract][Full Text] [Related]
9. Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.
Miya A; Yamamoto M; Morimoto H; Tanaka N; Shin E; Karakawa K; Toyoshima K; Ishizaka Y; Mori T; Takai S
Henry Ford Hosp Med J; 1992; 40(3-4):215-9. PubMed ID: 1362408
[TBL] [Abstract][Full Text] [Related]
10. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
[TBL] [Abstract][Full Text] [Related]
11. Detection of ret homodimers in MEN 2A-associated pheochromocytomas.
Wada M; Asai N; Tsuzuki T; Maruyama S; Ohiwa M; Imai T; Funahashi H; Takagi H; Takahashi M
Biochem Biophys Res Commun; 1996 Jan; 218(2):606-9. PubMed ID: 8561803
[TBL] [Abstract][Full Text] [Related]
12. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
13. C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B.
Smith-Hicks CL; Sizer KC; Powers JF; Tischler AS; Costantini F
EMBO J; 2000 Feb; 19(4):612-22. PubMed ID: 10675330
[TBL] [Abstract][Full Text] [Related]
14. Ganglioneuromas and renal anomalies are induced by activated RET(MEN2B) in transgenic mice.
Sweetser DA; Froelick GJ; Matsumoto AM; Kafer KE; Marck B; Palmiter RD; Kapur RP
Oncogene; 1999 Jan; 18(4):877-86. PubMed ID: 10023663
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile.
Powers JF; Evinger MJ; Zhi J; Picard KL; Tischler AS
Neuroscience; 2007 Jul; 147(4):928-37. PubMed ID: 17582688
[TBL] [Abstract][Full Text] [Related]
17. A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.
Califano D; D'Alessio A; Colucci-D'Amato GL; De Vita G; Monaco C; Santelli G; Di Fiore PP; Vecchio G; Fusco A; Santoro M; de Franciscis V
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7933-7. PubMed ID: 8755580
[TBL] [Abstract][Full Text] [Related]
18. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type.
Yoshimoto K; Tanaka C; Hamaguchi S; Kimura T; Iwahana H; Miyauchi A; Itakura M
Endocr J; 1995 Apr; 42(2):265-70. PubMed ID: 7627271
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
Ospina NS; Maraka S; Donegan D; Morris JC
Thyroid; 2017 Oct; 27(10):1332-1334. PubMed ID: 28747092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]